Literature DB >> 20823275

Expression of skeletal muscle sodium channel (Nav1.4) or connexin32 prevents reperfusion arrhythmias in murine heart.

Evgeny P Anyukhovsky1, Eugene A Sosunov, Yelena N Kryukova, Kevin Prestia, Nazira Ozgen, Mathilde Rivaud, Ira S Cohen, Richard B Robinson, Michael R Rosen.   

Abstract

AIMS: acute myocardial ischaemia induces a decrease in resting membrane potential [which leads to reduction of action potential (AP) V(max)] and intracellular acidification (which closes gap junctions). Both contribute to conduction slowing. We hypothesized that ventricular expression of the skeletal muscle Na(+) channel, Nav1.4 (which activates fully at low membrane potentials), or connexin32 (Cx32, which is less pH-sensitive than connexin43) would support conduction and be antiarrhythmic. We tested this hypothesis in a murine model of ischaemia and reperfusion arrhythmias. METHODS AND
RESULTS: empty adenovirus (Sham) or adenoviral constructs expressing either SkM1 (gene encoding Nav1.4) or Cx32 genes were injected into the left ventricular wall. Four days later, ventricular tachycardia (VT) occurred during reperfusion following a 5 min coronary occlusion. In Nav1.4- and Cx32-expressing mice, VT incidence and duration were lower than in Sham (P < 0.05). In vitro multisite microelectrode mapping was performed in the superfused right ventricular wall. To simulate ischaemic conditions, [K(+)] in solution was increased to 10 mmol/L and/or pH was decreased to 6.0. Western blots revealed Cx32 and Nav1.4 expression in both ventricles. Nav1.4 APs showed higher V(max) and conduction velocity (CV) than Shams at normal and elevated [K(+)]. Exposure of tissue to acid solution reduced intracellular pH to 6.4. There was no difference in CV between Sham and Cx32 groups in control solution. Acid solution slowed CV in Sham (P < 0.05) but not in Cx32.
CONCLUSION: Nav1.4 or Cx32 expression preserved normal conduction in murine hearts and decreased the incidence of reperfusion VT.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20823275      PMCID: PMC3002874          DOI: 10.1093/cvr/cvq284

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  33 in total

1.  Comparison of heterologously expressed human cardiac and skeletal muscle sodium channels.

Authors:  D W Wang; A L George; P B Bennett
Journal:  Biophys J       Date:  1996-01       Impact factor: 4.033

2.  Electrophysiological characteristics of cloned skeletal and cardiac muscle sodium channels.

Authors:  M Chahine; I Deschene; L Q Chen; R G Kallen
Journal:  Am J Physiol       Date:  1996-08

3.  Electrical resistances of interstitial and microvascular space as determinants of the extracellular electrical field and velocity of propagation in ventricular myocardium.

Authors:  J Fleischhauer; L Lehmann; A G Kléber
Journal:  Circulation       Date:  1995-08-01       Impact factor: 29.690

4.  Hetero-domain interactions as a mechanism for the regulation of connexin channels.

Authors:  K Stergiopoulos; J L Alvarado; M Mastroianni; J F Ek-Vitorin; S M Taffet; M Delmar
Journal:  Circ Res       Date:  1999-05-28       Impact factor: 17.367

5.  Reentry and fibrillation in the mouse heart. A challenge to the critical mass hypothesis.

Authors:  D Vaidya; G E Morley; F H Samie; J Jalife
Journal:  Circ Res       Date:  1999-07-23       Impact factor: 17.367

6.  Measurement of heart rate and Q-T interval in the conscious mouse.

Authors:  G F Mitchell; A Jeron; G Koren
Journal:  Am J Physiol       Date:  1998-03

7.  RXP-E: a connexin43-binding peptide that prevents action potential propagation block.

Authors:  Rebecca Lewandowski; Kristina Procida; Ravi Vaidyanathan; Wanda Coombs; José Jalife; Morten S Nielsen; Steven M Taffet; Mario Delmar
Journal:  Circ Res       Date:  2008-07-31       Impact factor: 17.367

8.  A structural basis for the unequal sensitivity of the major cardiac and liver gap junctions to intracellular acidification: the carboxyl tail length.

Authors:  S Liu; S Taffet; L Stoner; M Delmar; M L Vallano; J Jalife
Journal:  Biophys J       Date:  1993-05       Impact factor: 4.033

9.  Angina pectoris. I. A variant form of angina pectoris; preliminary report.

Authors:  M PRINZMETAL; R KENNAMER; R MERLISS; T WADA; N BOR
Journal:  Am J Med       Date:  1959-09       Impact factor: 4.965

10.  Epicardial border zone overexpression of skeletal muscle sodium channel SkM1 normalizes activation, preserves conduction, and suppresses ventricular arrhythmia: an in silico, in vivo, in vitro study.

Authors:  David H Lau; Chris Clausen; Eugene A Sosunov; Iryna N Shlapakova; Evgeny P Anyukhovsky; Peter Danilo; Tove S Rosen; Caitlin Kelly; Heather S Duffy; Matthias J Szabolcs; Ming Chen; Richard B Robinson; Jia Lu; Sinhu Kumari; Ira S Cohen; Michael R Rosen
Journal:  Circulation       Date:  2008-12-22       Impact factor: 29.690

View more
  10 in total

1.  Vitamin D receptor activation protects against myocardial reperfusion injury through inhibition of apoptosis and modulation of autophagy.

Authors:  Tianbao Yao; Xiaoying Ying; Yichao Zhao; Ancai Yuan; Qing He; Huan Tong; Song Ding; Junling Liu; Xu Peng; Erhe Gao; Jun Pu; Ben He
Journal:  Antioxid Redox Signal       Date:  2015-01-14       Impact factor: 8.401

Review 2.  Regenerative therapies in electrophysiology and pacing: introducing the next steps.

Authors:  Gerard J J Boink; Michael R Rosen
Journal:  J Interv Card Electrophysiol       Date:  2010-12-16       Impact factor: 1.900

3.  Effect of skeletal muscle Na(+) channel delivered via a cell platform on cardiac conduction and arrhythmia induction.

Authors:  Gerard J J Boink; Jia Lu; Helen E Driessen; Lian Duan; Eugene A Sosunov; Evgeny P Anyukhovsky; Iryna N Shlapakova; David H Lau; Tove S Rosen; Peter Danilo; Zhiheng Jia; Nazira Ozgen; Yevgeniy Bobkov; Yuanjian Guo; Peter R Brink; Yelena Kryukova; Richard B Robinson; Emilia Entcheva; Ira S Cohen; Michael R Rosen
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-06-21

4.  SCN4A variants and Brugada syndrome: phenotypic and genotypic overlap between cardiac and skeletal muscle sodium channelopathies.

Authors:  Véronique Bissay; Sophie C H Van Malderen; Kathelijn Keymolen; Willy Lissens; Uschi Peeters; Dorien Daneels; Anna C Jansen; Gudrun Pappaert; Pedro Brugada; Jacques De Keyser; Sonia Van Dooren
Journal:  Eur J Hum Genet       Date:  2015-06-03       Impact factor: 4.246

5.  SkM1 and Cx32 improve conduction in canine myocardial infarcts yet only SkM1 is antiarrhythmic.

Authors:  Gerard J J Boink; David H Lau; Iryna N Shlapakova; Eugene A Sosunov; Evgeny P Anyukhovsky; Helen E Driessen; Wen Dun; Ming Chen; Peter Danilo; Tove S Rosen; Nazira Őzgen; Heather S Duffy; Yelena Kryukova; Penelope A Boyden; Richard B Robinson; Peter R Brink; Ira S Cohen; Michael R Rosen
Journal:  Cardiovasc Res       Date:  2012-02-27       Impact factor: 10.787

Review 6.  Mutational consequences of aberrant ion channels in neurological disorders.

Authors:  Dhiraj Kumar; Rashmi K Ambasta; Pravir Kumar
Journal:  J Membr Biol       Date:  2014-08-14       Impact factor: 1.843

7.  Effects of different LAD-blocked sites on the development of acute myocardial infarction and malignant arrhythmia in a swine model.

Authors:  Xiaorong Li; Danbing Shao; Gannan Wang; Ting Jiang; Honghao Wu; Bing Gu; Kejiang Cao; Jinsong Zhang; Lianwen Qi; Yan Chen
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

8.  pH (low) insertion peptide (pHLIP) targets ischemic myocardium.

Authors:  Eugene A Sosunov; Evgeny P Anyukhovsky; Alexander A Sosunov; Anna Moshnikova; Dayanjali Wijesinghe; Donald M Engelman; Yana K Reshetnyak; Oleg A Andreev
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

9.  Cardiac electrophysiology in mice: a matter of size.

Authors:  Sven Kaese; Sander Verheule
Journal:  Front Physiol       Date:  2012-09-05       Impact factor: 4.566

10.  Cell and gene therapy for arrhythmias: Repair of cardiac conduction damage.

Authors:  Yong-Fu Xiao
Journal:  J Geriatr Cardiol       Date:  2011-09       Impact factor: 3.327

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.